Posted on 08 June 2021. Tags: Aducanumab, aging, Alzheimer's, Biogen, disease, drug, elderly, FDA
Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.
Read the full story
Posted in Health
Posted on 03 August 2018. Tags: Alzheimer's, Biogen, Dementia, drug, Eisai, treatment
An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study.
Read the full story
Posted in Health studies
Posted on 21 March 2015. Tags: Alzheimer's, Biogen, drug
Biogen Idec released much anticipated results from a study of a potential Alzheimer’s disease treatment on Friday, showing that it slowed cognitive decline in some patients. In December, the biotechnology company said the developing drug aducanumab reduced a type of plaque in the brain believed to play a key role in the disease and slowed […]
Read the full story
Posted in News